Abstract
Doxorubicin (DOX) is one of the most commonly used drugs in liver cancer. Unfortunately, the traditional chemotherapy with DOX presents many limitations, such as a systematic release of DOX, affecting both tumor tissue and healthy tissue, leading to the apparition of many side effects, multidrug resistance (MDR), and poor water solubility. Furthermore, drug delivery systems’ responsiveness has been intensively studied according to the influence of different internal and external stimuli on the efficiency of therapeutic drugs. In this review, we discuss both internal stimuli-responsive drug-delivery systems, such as redox, pH and temperature variation, and external stimuli-responsive drug-delivery systems, such as the application of magnetic, photo-thermal, and electrical stimuli, for the controlled release of Doxorubicin in liver cancer therapy, along with the future perspectives of these smart delivery systems in liver cancer therapy.
Funder
Ministry of Research, Innovation and Digitization, CNCS/CCCDI—UEFISCDI
Subject
Polymers and Plastics,General Chemistry
Reference226 articles.
1. Liver-directed therapies for patients with primary liver cancer and hepatic metastases;Arciero;Curr. Treat. Options Oncol.,2006
2. Hashem, B.E.S. (2006). Epidemiology of Hepatocellular Carcinoma. Digestive Disease Week, Sesion Handout Book.
3. Hepatocellular carcinoma: The need for progress;Thomas;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2005
4. Odze, R.D., and Goldblum, J.R. (2009). Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, W.B. Saunders. [2nd ed.].
5. Chemotherapy for hepatocellular carcinoma: The present and the future;Biagini;World J. Hepatol.,2017
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献